Pakistan: Import tariff reduction on medicine

Measure #1655 | Published 18 Aug 2010 ▲

Description

On 5 June 2010, the government lowered import tariffs on certain medicines. From that date imports of pharmaceuticals such as Protacine, Celecoxib, Sodium Casinate and Activated Glucuronate are subject to a reduced tariff of 5 percent.

Any Evidence-Based Deliberation:

Question Result
Is there anything in the public record to suggest that evidence of the effectiveness of the proposed measure was considered during official deliberations?
Is there any evidence that alternatives to the proposed measure were considered?
Is there anything in the public record that suggests that empirical evidence informed the comparison across the alternatives available to government?
Was such evidence identified?
Is such evidence publicly available?
Did the official decision-maker in question provide an explanation as to why a chosen measure was favoured over alternatives?
Is there any evidence to suggest that potentially affected trading partners were consulted before the measures were taken?
Is there any evidence that safeguards have been put in place to ensure that implementation of the initiative is transparent and non-discriminatory?
Did the government state its intention to review the measure within one year of implementation?

Implementing Jurisdiction:

Affected Trading Partners:


[view 5 more jurisdictions]

Measure type:

Affected Sectors:

Affected Tariff Lines:

(mouse over for more info)

Date Discovered:

Implemented: Yes

Date of inception: 5 Jun 2010

GTA Evaluation: Green

Source:

Pakistan Customs. (2010). Resolution 391. Available at http://www.fbr.gov.pk/dotnet/customs/admin/sroFiles/Customs/2010/2010sro...

Government Response:

Glossary of trade terms